MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Synthetic Biologics Company Profile (NYSE:SYN)

Consensus Ratings for Synthetic Biologics (NYSE:SYN) (?)
Ratings Breakdown: 1 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $6.50 (490.91% upside)

Analysts' Ratings History for Synthetic Biologics (NYSE:SYN)
Show:
DateFirmActionRatingPrice TargetActions
2/5/2016William BlairReiterated RatingOutperform$11.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016RBC CapitalReiterated RatingOutperform$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/25/2016William BlairReiterated RatingOutperform$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2016RBC CapitalReiterated RatingOutperform$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/4/2016Telsey Advisory GroupInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/1/2015RBC CapitalReiterated RatingPositive$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2015RBC CapitalInitiated CoverageOutperform$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015BTIG ResearchInitiated CoverageBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2015Griffin SecuritiesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/21/2015BTIG ResearchReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2015BTIG ResearchInitiated CoverageBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/23/2015Griffin SecuritiesReiterated RatingBuy$6.75 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2015HC WainwrightSet Price TargetBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015William BlairInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015Maxim GroupDowngradeBuy -> Hold$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Maxim GroupLower Price TargetBuy$6.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2014Maxim GroupBoost Price TargetBuy$3.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/13/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha